HIV感染者心血管疾病:全球背景下发病机制与临床表现的新见解
广泛使用现代抗逆转录病毒治疗使HIV成为慢性病,但HIV感染者仍面临超额心血管风险。高收入国家通过管理传统危险因素和早期启动抗逆转录病毒治疗降低了心肌梗死风险,但全球范围内缺血性结局风险仍升高。HIV相关心血管疾病具有独特的冠脉重塑扩张、 plaque形态异常、2型心梗比例高、主动脉病变和脑小血管病等特征,心衰表型从射血分数降低向保留转变,心肌纤维化在发病中起核心作用。
要点
- HIV感染者接受有效抗逆转录病毒治疗后仍存在超额缺血性心血管风险
- HIV相关冠心病表现为冠脉扩张重塑、非典型斑块和较高比例的2型心肌梗死
- 心衰表型转变:射血分数降低风险下降但仍存在,射血分数保留风险上升
核心结论
- HIV感染者即使接受有效抗逆转录病毒治疗,仍较无HIV者存在更高的心肌梗死和卒中风险。
- HIV相关心血管疾病具有独特的发病机制和临床表现,炎症是共同致病特征。
研究设计与样本
- 本文为综述,总结全球范围内HIV感染者心血管疾病的发病机制与临床表现新进展。
主要发现
- 高收入国家过去十年强调预防动脉粥样硬化性冠心病,包括积极管理传统危险因素和早期启动抗逆转录病毒治疗,降低了HIV感染者心肌梗死风险。
- HIV相关冠心病以冠脉扩张重塑和非典型斑块形态为特征,2型心肌梗死事件比例相对较高。
- HIV相关主动脉异常包括动脉瘤和弥漫性主动脉炎症,HIV脑血管病是卒中风险的Contributor。
- HIV相关心衰表型转变:射血分数降低心衰风险降低但仍持续,射血分数保留心衰风险增加。
- 心脏磁共振和尸检数据强调心肌内纤维化在射血分数保留心衰和心脏性猝死风险增加中的核心作用。
临床怎么用
- 对HIV感染者应积极管理传统心血管危险因素并尽早启动抗逆转录病毒治疗以降低心肌梗死风险。
- 临床需认识HIV相关心血管疾病的独特表型,包括冠脉扩张重塑、2型心梗比例高和射血分数保留心衰风险增加。
局限性
- 需要更多研究来更好地表征当前时代HIV相关心肌病的 underlying mechanisms 和临床表型。
- HIV相关心血管疾病的表现和表型受HIV疾病损伤程度和基础心血管代谢因素影响,全球各地差异显著。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Widespread use of contemporary antiretroviral therapy globally has transformed HIV disease into a chronic illness associated with excess risk for disorders of the heart and circulatory system. Current clinical care and research has focused on improving HIV-related cardiovascular disease outcomes, survival, and quality of life. In high-income countries, emphasis on prevention of atherosclerotic coronary artery disease over the past decade, including aggressive management of traditional risk factors and earlier initiation of antiretroviral therapy, has reduced risk for myocardial infarction among persons living with human immunodeficiency virus-1 infection. Still, across the globe, persons living with human immunodeficiency virus-1 infection on effective antiretroviral therapy treatment remain at increased risk for ischemic outcomes such as myocardial infarction and stroke relative to the persons without HIV. Unique features of HIV-related cardiovascular disease, in part, include the pathogenesis of coronary disease characterized by remodeling ectasia and unusual plaque morphology, the relative high proportion of type 2 myocardial infarction events, abnormalities of the aorta such as aneurysms and diffuse aortic inflammation, and HIV cerebrovasculopathy as a contributor to stroke risk. Literature over the past decade has also reflected a shift in the profile and prevalence of HIV-associated heart failure, with a reduced but persistent risk of heart failure with reduced ejection fraction and a growing risk of heart failure with preserved ejection fraction. Cardiac magnetic resonance imaging and autopsy data have emphasized the central importance of intramyocardial fibrosis for the pathogenesis of both heart failure with preserved ejection fraction and the increase in risk of sudden cardiac death. Still, more research is needed to better characterize the underlying mechanisms and clinical phenotype of HIV-associated myocardial disease in the current era. Across the different cardiovascular disease manifestations, a common pathogenic feature is that HIV-associated inflammation working through different mechanisms may amplify underlying pathology because of traditional risk and other host factors. The prevalence and phenotype of individual cardiovascular disease manifestations is ultimately influenced by the degree of injury from HIV disease combined with the profile of underlying cardiometabolic factors, both of which may differ substantially by region globally.
引用
- Ntsekhe M, Baker JV. Cardiovascular Disease Among Persons Living With HIV: New Insights Into Pathogenesis and Clinical Manifestations in a Global Context. Circulation. 2022. PMID: 36576956. doi:10.1161/CIRCULATIONAHA.122.057443
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。